Stocktoria

INTENSITY THERAPEUTICS, INC. INTS

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2023-06-30

INTENSITY THERAPEUTICS, INC. statistics & valuation

Market cap$11.1M
P / B0.9×
Return on equity-97.7%
Return on capital-100.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2022202320242025
Operating margin (%)
2022202320242025
Return on equity (%)
-80.10% -557.50% -97.70% 2022202320242025
Shares outstanding
3.4M 13.7M 604915 2.5M 2022202320242025
Net debt ($)
2022202320242025
Share buybacks ($)
2022202320242025
Return on assets (%)
-431.50% -60.90% -340.10% -82.30% 2022202320242025
Free cash flow margin (%)
2022202320242025
Debt / equity (×)
2022202320242025
EPS ($)
-$2.22 -$1.38 -$29.24 -$8.56 2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Return on assets-82.3%-340.1%-60.9%-431.5%
Return on equity-97.7%-557.5%-80.1%50.2%
Current ratio5.921.923.910.21

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.